GlassScriptPhysician profile
Lillian J Theune
NPI 1053383869
$7,393.89
in general payments reported to CMS, 2019-2025
42 companies · $1,768 in 2025
The $1,768 reported for 2025 was more than what 92% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $166 · 2021: $1,028 · 2022: $1,202 · 2023: $1,371 · 2024: $1,859 · 2025: $1,768.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,962 · Education: $36.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,961.97 |
| Education | $36.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,186.17 | 2020-2025 | Repatha, Otezla, Repatha |
| Abbvie INC. | $1,089.61 | 2021-2025 | Vraylar, Ubrelvy, Qulipta |
| Novo Nordisk INC | $866.01 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $670.72 | 2020-2025 | Breztri, Farxiga, Airsupra |
| Pfizer INC. | $469.62 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $410.29 | 2022-2025 | |
| Esperion Therapeutics, INC. | $248.63 | 2021-2025 | Nexletol |
| Lilly USA, LLC | $242.89 | 2021-2025 | Jardiance, Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $241.00 | 2021-2025 | Jardiance |
| Glaxosmithkline, LLC. | $198.43 | 2021-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Otsuka America Pharmaceutical, INC. | $179.22 | 2023-2025 | Rexulti |
| Astellas Pharma US INC | $139.73 | 2024-2025 | Veozah |
| Axsome Therapeutics, INC. | $135.51 | 2024-2025 | Auvelity |
| Merck Sharp & Dohme LLC | $127.22 | 2021-2025 | Capvaxive, Gardasil 9 |
| Boston Scientific Corporation | $120.75 | 2022 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $110.37 | 2023-2025 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $89.69 | 2021-2022 | |
| Abbott Laboratories | $80.35 | 2021-2025 | Freestyle Libre 3 |
| Kaleo, INC. | $79.14 | 2020-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $62.44 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $59.59 | 2020-2025 | Zoryve |
| Amarin Pharma, INC. | $56.49 | 2021 | |
| Arbor Pharmaceuticals, INC. | $43.64 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $43.22 | 2020-2023 | Ajovy |
| Lexicon Pharmaceuticals, INC. | $43.10 | 2023-2024 | Inpefa |
| Lundbeck LLC | $37.19 | 2024-2025 | Rexulti |
| Dexcom, INC. | $36.90 | 2021-2023 | Dexcom G6 Transmitter |
| Azurity Pharmaceuticals, INC. | $35.40 | 2024 | Horizant, Edarbi |
| Regeneron Healthcare Solutions, INC. | $35.23 | 2025 | Evkeeza |
| Currax Pharmaceuticals LLC | $33.06 | 2024-2025 | Contrave |
| Ibsa Pharma INC. | $28.18 | 2022 | |
| Horizon Therapeutics Plc | $26.99 | 2020 | |
| Xeris Pharmaceuticals, INC. | $23.17 | 2024 | Gvoke Hypopen |
| Cvrx, INC. | $20.84 | 2024 | Barostim Neo System |
| Eisai INC. | $19.13 | 2025 | |
| Angiodynamics, INC. | $17.02 | 2023 | Auryon Laser System 100-120 Vac |
| Collegium Pharmaceutical, INC. | $15.80 | 2025 | Jornay Pm |
| E.R. Squibb & Sons, L.L.C. | $15.68 | 2025 | Camzyos |
| Bausch Health US, LLC | $14.92 | 2021 | |
| Allergan, INC. | $14.10 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $13.62 | 2021 | |
| Sanofi-Aventis U.S. LLC | $12.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lillian Theune listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.